Expertise in
12
conditions

Ruth L. Ladenstein

St. Anna Children's Hospital, 
Vienna, AT 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
12
conditions
St. Anna Children's Hospital, 
Vienna, AT 

Overview

Ruth Ladenstein practices practicing medicine in Vienna, Austria.

Ms. Ladenstein is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Bone Marrow Transplant, and Osteotomy.

She is actively involved in clinical research, co-authoring 153 peer reviewed articles and participating in 5 clinical trials.

Gender

Female

Locations

St. Anna Children's Hospital, Vienna, 1090, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta
A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta
Enrollment Status: Recruiting
Publish Date: February 07, 2024
Intervention Type: Other
A Randomised Phase IIb Trial of Bevacizumab Added to Temozolomide ± Irinotecan for Children With Refractory/Relapsed Neuroblastoma - BEACON-Neuroblastoma Trial
A Randomised Phase IIb Trial of Bevacizumab Added to Temozolomide ± Irinotecan for Children With Refractory/Relapsed Neuroblastoma - BEACON-Neuroblastoma Trial
Enrollment Status: Completed
Publish Date: May 12, 2026
Intervention Type: Drug
Study Drugs: Bevacizumab, Temozolomide, Irinotecan, Topotecan, Dinutuximab Beta, Cyclophosphamide
Study Phase: Phase 2
Multinational European Trial for Children With the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome
Multinational European Trial for Children With the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome
Enrollment Status: Completed
Publish Date: February 03, 2025
Intervention Type: Drug
Study Drugs: Dexamethasone Acetate, Dexamethasone and Cyclophosphamide, Dexamethasone and Rituximab
Study Phase: Phase 3
Phase II Feasability Study Using ch14.18/CHO Antibody and Subcutaneous Interleukin 2 After Haploidentical Stem Cell Transplantation in Children With Relapsed Neuroblastoma
Phase II Feasability Study Using ch14.18/CHO Antibody and Subcutaneous Interleukin 2 After Haploidentical Stem Cell Transplantation in Children With Relapsed Neuroblastoma
Enrollment Status: Completed
Publish Date: December 08, 2023
Intervention Type: Drug
Study Drug: ch14.18/CHO
Study Phase: Phase 2
A Phase I/II Dose Schedule Finding Study of ch14.18/CHO Continuous Infusion Combined With Subcutaneous Aldesleukin (IL-2) in Patients With Primary Refractory or Relapsed Neuroblastoma
A Phase I/II Dose Schedule Finding Study of ch14.18/CHO Continuous Infusion Combined With Subcutaneous Aldesleukin (IL-2) in Patients With Primary Refractory or Relapsed Neuroblastoma
Enrollment Status: Unknown
Publish Date: July 14, 2020
Intervention Type: Drug
Study Drugs: ch14.18/CHO, Aldesleukin, Isotretinoin
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials

153 Total Publications

Long-Term Analysis of Patients With Ewing Sarcoma Included in the Euro-EWING99 Study.
Long-Term Analysis of Patients With Ewing Sarcoma Included in the Euro-EWING99 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 31, 2026

Frequently Asked Questions about Ruth L. Ladenstein

Is Ruth L. Ladenstein a top-rated expert for Neuroblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Ruth L. Ladenstein is classified as an Elite expert for Neuroblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ruth L. Ladenstein participate in research or clinical trials?

Yes. Ruth L. Ladenstein has published 153 articles and abstracts on conditions like Neuroblastoma. You can view a list of Ruth L. Ladenstein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ladenstein's expertise for a condition
ConditionClose
View All 15 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile